Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2011 23:00 ET | Source: MediciNova, Inc.

MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.

SAN DIEGO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
September 26, 2011 02:30 ET | Source: MediciNova, Inc.

MediciNova, Inc. Appoints Mr. Tatsuo Izumi to Its Board of Directors

SAN DIEGO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
September 02, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Announces Management Appointments

SAN DIEGO, Sept. 2, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
August 16, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Second Quarter 2011 Results

SAN DIEGO, Aug. 16, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
August 11, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Announces Second Quarter 2011 Earnings Conference Call and Webcast

SAN DIEGO, Aug. 11, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
August 10, 2011 19:00 ET | Source: MediciNova, Inc.

MediciNova to Collaborate on a Phase 2 Trial of Ibudilast (MN-166/AV411) in Medication Overuse Headache

SAN DIEGO, Aug. 10, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
June 29, 2011 19:00 ET | Source: MediciNova, Inc.

Chinese Joint Venture Completed

SAN DIEGO, June 29, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
May 17, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports First Quarter 2011 Results

SAN DIEGO, May 17, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
May 11, 2011 17:00 ET | Source: MediciNova, Inc.

MediciNova Announces First Quarter 2011 Earnings Conference Call and Webcast

SAN DIEGO, May 11, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
April 07, 2011 06:00 ET | Source: MediciNova, Inc.

Reminder: MediciNova to Host Business Update Conference Call by Management on April 7, 2011

SAN DIEGO, April 7, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...